share_log

US FDA Allows 3D Medicines' Phase II Study for Tumor Treatment to Proceed

US FDA Allows 3D Medicines' Phase II Study for Tumor Treatment to Proceed

美國FDA允許3D Medicines的腫瘤治療第二階段研究繼續進行
MT Newswires ·  2023/01/01 23:00

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論